Cancer Center Esslingen CCE


Lymphome

HD21 for advanced stages

Therapieoptimierungsstudie in der Primärtherapie des fortgeschrittenen Hodgkin Lymphoms; Vergleich 6 Zyklen BEACOPPesk mit 6 Zyklen BrECADD

DADA
Daratumumab for first line treatment of transplant-ineligible myeloma patients followed by daratumumab re-treatment at first relapse

Stand 14.04.2023